GINO BIOW Chart calendar GINO BIOW
3b7de7e5fc2bdea46d3d9.lPGW2Y_-NgtfoidCUIA7tkx6_dwdPbwJ6od_2mVmuTk.orrkgcSrVTxm8nAdHuNLxj0ozu9sTf1Tp8ksiQlW7A3kgeWy4YZkZA7JFw~f7d5a619ec1e51f89455b69cbe7bdb2f
Upcoming events on GINO BIOW
Past events on GINO BIOW
| 2024-05-22 04:25 pm | TD Cowen Sustainability Week |
| 2024-05-11 10:45 am | American Society of Gene & Cell Therapy Meeting - Abstract No: 410 |
| 2024-05-10 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No:1672 |
| 2024-05-09 05:30 pm | Q1 2024 Earnings Call |
| 2024-05-09 04:01 pm | Q1 2024 Earnings Release |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No: 826 |
| 2024-05-08 12:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No: 821 |
| 2024-03-05 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-29 05:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 05:01 pm | Q4 2023 Earnings Release |
| 2024-01-10 12:45 pm | JPMorgan Healthcare Conference |
| 2023-11-08 05:30 pm | Q3 2023 Earnings Call |
| 2023-11-08 05:01 pm | Q3 2023 Earnings Release |
| 2023-10-03 10:00 am | Investor Day |
| 2023-09-13 12:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-15 05:00 pm | UBS MedTech Tools and Genomics Summit |
| 2023-08-09 05:30 pm | Q2 2023 Earnings Call |
| 2023-08-09 05:01 pm | Q2 2023 Earnings Release |
| 2023-06-16 04:00 pm | Annual General Meeting |
| 2023-06-12 07:40 pm | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 314 250 25.36% | 478 472 1.31% | 251 259 -2.81% | 193 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -106 -142 25.54% | -173 -182 5.2% | -355 -392 9.36% | -384 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -1 828 -185 -888.68% | -2 209 -2 361 6.45% | -864 -832 -3.86% | -613 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -1 838 -297 -518.76% | -2 121 -2 296 7.6% | -893 -837 -6.66% | -579 |
|
Net income Million USD | Released Forecast Spread | -127 | -1 830 -301 -507.08% | -2 105 -2 324 9.44% | -893 -837 -6.64% | -579 |
|
EPS USD | Released Forecast Spread | -16,2 | -1,35 -0,19 -595.16% | -1,25 -1,42 12.13% | -0,46 -0,44 -4.55% | -0,29 |
| Announcement Date | 14/05/21 | 28/03/22 | 01/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 168 106 59.38% | 145 77,6 86.34% | 66,4 60,4 9.87% | 98,3 88,9 10.6% | 80,7 71,7 12.49% | 80,6 71,5 12.66% | 55,4 48,1 15.32% | 34,8 42,6 -18.32% | 37,9 46,0 -17.58% | 46,5 | 51,3 | 57,1 | 59,0 | 71,7 |
|
EBITDA Million USD | Released Forecast Spread | -1,95 -146 98.66% | -23,3 -48,3 51.67% | -69,6 73,1 -195.25% | -80,2 -78,4 -2.3% | -100 -69,2 -44.5% | -75,5 -83,7 9.84% | -83,8 -104 19.22% | -95,8 -131 27.01% | -100 -92,1 -8.7% | -79,3 | -67,2 | -54,4 | -74,0 | -66,1 |
|
EBIT Million USD | Released Forecast Spread | -675 -184 -266.29% | -647 -408 -58.56% | -653 -462 -41.34% | -235 -307 23.62% | -216 -147 -47.1% | -184 -172 -7.28% | -286 -165 -73.44% | -178 -157 -13.7% | -178 -168 -5.66% | -163 | -151 | -139 | -136 | -139 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -593 -243 -144.24% | -671 -282 -137.64% | -669 -349 -91.52% | -189 -273 30.75% | -205 -145 -40.86% | -173 -144 -20.48% | -303 -152 -99.61% | -212 -136 -55.8% | -166 -169 2.08% | -167 | -167 | -165 | -154 | -148 |
|
Net income Million USD | Released Forecast Spread | -591 -283 -108.5% | -669 -326 -105.17% | -669 -410 -63.38% | -177 -343 48.46% | -205 -159 -28.65% | -173 -165 -5.16% | -303 -164 -85.19% | -212 -136 -55.77% | -166 -162 -2.28% | -142 | -122 | -110 | -154 | -148 |
|
EPS USD | Released Forecast Spread | -0,37 -0,17 -114.49% | -0,41 -0,14 -201.47% | -0,41 -0,21 -97.59% | -0,10 -0,21 51.61% | -0,11 -0,09 -25% | -0,09 -0,09 -1.89% | -0,16 -0,09 -88.24% | -0,11 -0,10 -13.79% | -0,08 -0,08 4% | -0,08 | -0,07 | -0,06 | -0,07 | -0,07 |
| Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 08/11/23 | 29/02/24 | 09/05/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for GINO BIOW
| 2024-05-21 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-21 | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 01:50 am | BELITE BIO, INC: Q1 2024 Earnings Release |
